Document Type : Original Article


1 PhD Candidate, Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

2 Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran


Neuroprotective effects for natural products are supported by several studies. In this regard, safranal, a constitute of saffron, has the potential to exert beneficial effects in neurological disorders such as Parkinson's disease, epilepsy, stroke, multiple sclerosis and Alzheimer's disease. Here, we investigated the effect of safranal on penicillin-induced epileptiform activity. Also, the effects of intracerebroventricular (ICV) microinjection of AM251 as a CB1-cannabinoid receptors antagonist to clarify the possible mechanism of safranal were evaluated. Epileptiform activity was induced by intra-cortical administration of penicillin (300 IU, 1.50 μL) in urethane-anesthetized rats. Electrocorticographic recordings were used to analyze the frequency and amplitude of spike waves. Intraperitoneal injections of safranal at doses of 1.00 and 4.00 mg kg-1 significantly reduced both the number and amplitude of spike waves. The ICV microinjection of AM251 (0.50 μg 2.00 μL-1) significantly increased the frequency and amplitude of spike waves. In addition, the anti-epileptic effect induced by administration of safranal at a dose of 4.00 mg kg-1 was partially prevented by ICV microinjection of 0.50 μg 2.00 μL-1 of AM251. The results showed anti-epileptiform activities for safranal. Central CB1 cannabinergic receptors might be involved in the anti-epileptiform activity of safranal.


Main Subjects

  1. Kada H, Teramae JN, Tokuda IT. Effective suppression of pathological synchronization in cortical networks by highly heterogeneous distribution of inhibitory connections. Front Comput Neurosci 2016; 10: 109. doi: 10.3389/fncom.2016.00109.
  2. Kozan R, Sefil F, Bağirici F. Anticonvulsant effect of carnosine on penicillin-induced epileptiform activity in rats. Brain Res 2008; 1239: 249-255.
  3. Erfanparast A, Tamaddonfard E. Effects of intracortical microinjection of vitamin B12 on penicillin-induced epileptiform activity in rats. Acta Neurobiol Exp (Wars) 2015; 75(2): 200-207.
  4. Kayacan Y, Kisa EC, Ghojebeigloo BE, et al. The effects of moderate running exercise and L-tyrosine on penicillin-induced epileptiform activity in rats. Acta Neurobiol Exp (Wars) 2019; 79(2): 148-154.
  5. Rossokhin AV, Sharonova IN, Bukanova JV, et al. Block of GABA(A) receptor ion channel by penicillin: electrophysiological and modeling insights toward the mechanism. Mol Cell Neurosci 2014; 63: 72-82.
  6. Rameshrad M, Razavi BM, Hosseinzadeh H. Saffron and its derivatives, crocin, crocetin and safranal: a patent review. Expert Opin Ther Pat, 2018; 28(2): 147-165.
  7. Fotoohi A, Moloudi MR, Hosseini S, et al. A novel pharmacological protective role for safranal in an animal model of Huntington’s disease. Neurochem Res 2021; 46(6): 1372-1379.
  8. Zhao Y, Xi G. Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease. Pharm Biol 2018; 56(1): 450-454.
  9. Baluchnejadmojarad T, Mohamadi-Zarch SM, Roghani M. Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer’s disease: underlying mechanisms. Metab Brain Dis 2019; 34(6): 1747-1759.
  10. Hosseinzadeh H, Talebzadeh F. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 2005; 76(7-8): 722-724.
  11. Wu J. Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow. Acta Pharmacol Sin 2019; 40(3): 297-299.
  12. Lu HC, Mackie K. An introduction to the endogenous cannabinoid system. Biol Psychiatry 2016; 79(7): 516-525.
  13. Franco V, Crema F, Iudice A, et al. Novel treatment options for epilepsy: focus on perampanel. Pharmacol Res 2013; 70(1): 35-40.
  14. St Louis EK. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 2009; 7(2): 106-114.
  15. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th New York, USA: Elsevier, 2007; 116.
  16. Wanleenuwat P, Suntharampillai N, Iwanowski P. Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations. Seizure 2020; 81: 167-174.
  17. Arslan G, Avci B, Kocacan SE, et al. The interaction between P2X7Rs and T-type calcium ion channels in penicillin-induced epileptiform activity. Neuropharmacology 2019; 149: 1-12.
  18. Tutkun E, Arslan G, Soslu R, et al. Long-term ascorbic acid administration causes anticonvulsant activity during moderate and long-duration swimming exercise in experimental epilepsy. Acta Neurobiol Exp (Wars) 2015; 75(2): 192-199.
  19. Tamaddonfard E, Gooshchi NH, Seiednejad-Yamchi S. Central effect of crocin on penicillin-induced epileptiform activity in rats. Pharmacol Rep 2012; 64(1): 94-101.
  20. Tamaddonfard E, Erfanparast A, Hamzeh-Gooshchi N, et al. Effect of curcumin, the active constituent of turmeric, on penicillin-induced epileptiform activity in rats. Avicenna J Phytomed 2012; 2(4): 196-205.
  21. Yildirim M, Marangoz AH, Ayyildiz M, et al. The interactions of nitric oxide and adenosine on penicillin-induced epileptiform activity in rats. Acta Neurobiol Exp (Wars) 2011; 71(2): 208-219.
  22. Tamaddonfard E, Farshid AA, Maroufi S, et al. Effects of safranal, a constituent of saffron, and vitamin E on nerve functions and histopathology following crush injury of sciatic nerve in rats. Phytomedicine 2014; 21(5): 717-723.
  23. Hosseinzadeh H, Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L stigmas in mice. Arch Irn Med 2002; 5(1): 44-47.
  24. Sadeghnia HR, Cortez MA, Liu D, et al. Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography. J Pharm Pharm Sci 2008; 11(3): 1-14.
  25. Hosseinzadeh H, Sadeghnia HR, Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 2007; 14(4): 256-262.
  26. Saberi F, Saberi M, Sayyah M, et al. The antiepileptic activity of Safranal in kindling model of epilepsy in male rats. Braz J Pharm Sci (Online) 2022; 58: e20066. doi: 10.1590/s2175-97902022e20066.
  27. Kendall DA, Yudowski GA. Cannabinoid receptors in the central nervous system: their signaling and roles in disease. Front Cell Neurosci 2017; 10: 294. doi: 10.3389/fncel.2016.00294
  28. Gloss D, Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2014; 2014(3): CD009270. doi: 10.1002/14651858.CD009270.pub3.
  29. Nabbout R, Thiele EA, The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials. Epileptic Disord 2020; 22(S1): 23-28.
  30. Arslan G, Alici SK, Ayyildiz M, et al. The role of CB1‐receptors in the proconvulsant effect of leptin on penicillin‐induced epileptiform activity in rats. CNS Neurosci Ther 2013; 19(4): 222-228.
  31. Arslan G, Ayyildiz M, Agar E. The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats. Neuropeptides 2014; 48(6): 345-352.
  32. Blair RE, Deshpande LS, Sombati S, et al. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 2006; 317(3): 1072-1078.
  33. Deshpande LS, Sombati S, Blair RE, et al. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 2007; 411(1): 11-16.
  34. Monory K, Massa F, Egertová M, et al. The endo-cannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006; 51(4): 455-466.
  35. Naderi N, Shafieirad E, Lakpoor D, et al. Interaction between cannabinoid compounds and capsazepine in protection against acute pentylenetetrazole-induced seizure in mice. Iran J Pharm Res 2015; 14(Suppl): 115-120.
  36. Naderi N, Ahari FA, Shafaghi B, et al. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J Neural Transm (Vienna) 2008; 115(11): 1501-1511.
  37. Vafaei AA, Safakhah HA, Jafari S, et al. Role of cannabinoid receptors in crocin-induced hypoalgesia in neuropathic pain in rats. J Exp Pharmacol 2020; 12: 97-106.